Speakers

13

Professor Anne Greenough

King's College, London, UK

Anne Greenough is Professor of Neonatology and Clinical Respiratory Physiology, Director of Education and Training at King’s Heath Partners Academic Health Science Centre and Board Member of the Higher Education Funding Council for England.  She was Chair of the National Institute for Health Research (NIHR) Paediatrics (non medicines) Specialty Group and is now Vice President Science and Research, Royal College of Paediatrics and Child Health.  Professor Greenough is a member of the KCL/Imperial Medical Research Council–Asthma UK Centre in Allergic Mechanisms of Asthma. Her research interests focus on the early origins of chronic respiratory disease which include factors affecting antenatal lung growth, optimisation of respiratory support, determinants of sudden infant death syndrome and prevention and treatment of chronic lung disease, particularly related to viral infections and sickle cell disease. 

Professor Steven Donn

Ann Arbor, Michigan, USA

Steven M Donn, M.D. was born and raised in the New York Metropolitan area. He obtained his undergraduate training at the University of Michigan in Ann Arbor, graduating with a B.A. degree, majoring in zoology and German literature. He attended Tulane University's School of Medicine in New Orleans, receiving his M.D. degree. His training in general pediatrics occurred at the University of Vermont College of Medicine-Medical Center Hospital of Vermont in Burlington. He returned to Ann Arbor for fellowship training in Neonatal-Perinatal Medicine at the University of Michigan Health System, where he has served continuously since 1980. Dr Donn is a Professor of Pediatrics at the University of Michigan Medical School and is a neonatologist in the Division of Neonatal-Perinatal Medicine at C.S. Mott Children's Hospital at the University of Michigan Health System.


 

Prof. Donn's professional interests include high technology support of neonatal respiratory failure and surfactant replacement therapy, neonatal brain injury, and medical liability. He has authored more than 250 scientific articles and 230 book chapters and has written or edited 33 books and specialty journals in neonatology. He is the Editor-in-Chief of Seminars in Fetal & Neonatal Medicine and was a co-editor of the Year Book of Neonatal-Perinatal Medicine. He is a member of numerous scientific organizations including the Society for Pediatric Research, European Society for Pediatric Research, and the American Pediatric Society. He is a Fellow of the American Academy of Pediatrics and served as the Chair of its Committee on Medical Liability and Risk Management.  He was a voting member of the Anesthesia and Respiratory Devices Specialty Panel of the U.S. Food and Drug Administration and represents medical subspecialists as a member of the National Practitioner Data bank. His extracurricular interests include tennis, spectator sports (Go Blue!), astronomy (especially total solar eclipses), photography, travel, and raising German Shepherds.

Professor Anton Van Kaam

Emma Children's Hospital, Amsterdam, Netherlands

Anton Van Kaam is currently the Professor of Neonatology, Head Neonatal Intensive Care Unit at Emma Children's Hospital, Academic Medical Center and VU Medical Center, Amsterdam in The Netherlands.

Professor Donald Peebles

University College Hospital, London, UK

Professor Donald Peebles is a graduate of Cambridge University and then Guys and St Thomas’s Medical School.  He completed his obstetric training with Professor Charles Rodeck at University College London and was appointed to UCLH as a Consultant with sub-specialty accreditation in Maternal Fetal medicine in 1990.  He co-leads a multidisciplinary clinical team including specialist midwives, haematologists, obstetric medicine, cardiologists and anaesthetists providing a tertiary level referral service for complex pregnancies in NCI London.  In addition, he provides a range of diagnostic and therapeutic services on the Fetal Medicine unit with particular interests in the management of fetal growth restriction as well as the management of fetal rhesus disease.  He is a faculty member of the Infection, Inflammation and Immunity Theme of the NIHR UCLH Biomedical Research Centre.

 

He has been Health of the Research Department of Maternal Fetal Medicine at UCL since 2008.  He has a number of research interests that focus on improving the outcomes for women and their babies following complicated pregnancies.  Particular research areas include: 1) maternal innate immunity, infection, inflammation and preterm labour, 2) the role of hypoxia and inflammation in causation of perinatal brain injury, 3) fetal physiology and 4) the development of novel molecular and cellular methods for treatment of fetal disease.

 

He is the President of the Blair Bell Research Society, the showcase for British research in Obstetrics and Gynaecology as well as a member of the Academic Committee of the Royal College of Obstericians and Gynaecologists.  In 2013 he was appointed as co clinical lead for the NHS England London Maternity Strategic Clinical Network.  He is currently Divisional Clinical Director for Women’s Health.

Professor Colm O'Donnell

National Maternity Hospital, Dublin, Ireland

Colm O’Donnell is a Consultant Neonatologist at the National Maternity Hospital, Dublin, Ireland; Professor at the School of Medicine, University College Dublin; and Director of Clinical Research at the National Children’s Research Centre. He trained in General Medicine and Paediatrics in Ireland before moving to Melbourne, Australia to pursue further training in Neonatology. He was awarded a PhD by the University of Melbourne for his research on resuscitation of newborns; and was a Consultant Neonatologist at the Royal Women’s Hospital and at the Newborn Emergency Transport Service, Victoria. Since returning to Ireland in 2006, he has combined clinical research with a busy clinical workload. He has led many randomised clinical trials of interventions in the delivery room and neonatal intensive care unit, including international multicentre trials and trials of investigational medicinal products. He is the Chief Investigator of the POPART study, an international multicentre randomised controlled trial of prophylactic oropharyngeal surfactant at birth to prevent respiratory failure in premature babies. POPART is supported by PedCRIN, an initiative of the European Union’s Horizon 2020 funding programme, and provides some respite from the demands of juvenile Camogie management and a burgeoning career in rock.

 

Dr Michael Wright

Institute of Genetic Medicine, Newcastle upon Tyne, UK

Dr Michael Wright is a Consultant in Clinical Genetics at the Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne.  His special interests include paediatric genetics and musculoskeletal genetics.

Professor Simon Stanworth

John Radcliffe Hospital, Oxford, UK

Dr Simon Stanworth is a Consultant Haematologist for NHSBT at the John Radcliffe Hospital (Oxford University Hospitals Foundation Trust), and honorary senior clinical lecturer at the University of Oxford.  He has over 15 years of clinical research experience since gaining his PhD in 1995 from the University of Oxford.  His research is centred on clinical indications of blood transfusion components, through systematic reviews and clinical studies/trials.  Highlights have included several international randomized trials published in NEJM.  He has published extensively, having over 150 peer-reviewed research articles, with an h-index 48; more recently he has been involved with 5 national guidelines.  He is secretary of the South Central Regional Transfusion Committee.  Dr Stanworth is a current scientific member of the BEST Collaborative from 2007.

Professor Alan Jobe

Cincinnati Children's Hospital, Cleveland, USA

Dr Jobe is a neonatologist and Professor of Pediatrics at Cincinnati Children’s Hospital.  His research contributions include studies of surfactant metabolism, the hormonal regulation of lung maturation, mechanisms of lung injury with mechanical ventilation, and neonatal resuscitation.  He has been Chair of the NICHD Neonatal Research Network Steering Committee and Chair of the NICHD Global Research Network Steering Committee. He has a 28-year collaborative research project on fetal development with Professor John Newnham at the University of Western Australia.  He remains actively involved with clinical and translational research to improve outcomes for infants.  He was an Associate Editor for Journal of Pediatrics for 18 years.    Noteworthy recognitions are the E. Mead Johnson Award for Pediatric Research, the Virginia Apgar Award from the AAP, the Mary Ellen Avery Award from the SPR and APS, and election to the US National Academy of Medicine.

 

Professor Robert Christensen

Saratoga Springs, Utah, USA

Robert D. Christensen was born in Salt Lake City, graduated from the University of Utah in Genetic and Molecular Biology, received his MD degree from Columbia University College of Physicians and Surgeons in New York City, and obtained his Pediatrics Residency training at Stanford University Hospital. He was further trained in Neonatology and Hematology at the University of Utah. In 1993 he was appointed Professor and Chief of Neonatology at the University of Florida School of Medicine in Gainesville. In 1999 he was appointed Chairman of the Department of Pediatrics at the University of South Florida in Tampa, and Physician-in-Chief of All Children’s Hospital in St. Petersburg Florida. In 2004 he became Director of Neonatology Research at Intermountain Healthcare and in 2015 was appointed as Presidential Endowed Chair and Chief of the Division of Neonatology at the University of Utah. Dr. Christensen’s academic work involves blood problems of newborn infants. He has published over 500 articles in medical and research journals and written two textbooks on Neonatal Hematology.

 

Professor Elaine Boyle

University of Leicester, Leicester, UK

Elaine Boyle is Professor of Neonatal Medicine at the University of Leicester and Honorary Consultant Neonatologist at the University Hospitals of Leicester NHS Trust. She initially trained as a nurse and worked in nursing for a number of years before changing direction to study medicine at the University of Sheffield, qualifying as a doctor in 1993. Elaine completed postgraduate training in paediatrics in Sheffield and Birmingham. Before taking up her post in Leicester in 2006, she trained in academic neonatal medicine in Edinburgh, and at McMaster University, Canada. During this time she gained an MD for work on the assessment and management of pain in the newborn, an MSc in Epidemiology, and a PhD focused on enteral feeding in preterm neonates.  She remains active in each of these areas of research, most recently as a co-investigator and UK National Principal Investigator for the EU-funded Europain Survey, and as a co-investigator on the UK multicenter SIFT - Speed of Increasing milk Feeds Trial. Her current major research interest is the effects of gestational age at birth on neonatal and childhood outcomes, and in particular the effects of moderate-late preterm and early term birth. She was the lead for the LAMBS - Late And Moderately preterm Birth Study, one of the first large population-based studies in this area.